Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease

ConclusionUltimately, ENA739155_Evo with -CDOCKER_ENERGY of 47.12, estimate activity of 0.012, fit value of 10.02 could be further subjected to drug development and forwarded as better alternatives to the current batch of medicines used for the treatment of AD.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research